The numbers behind the dry mouth paragraph
Zepbound®’s main US side-effect table admits only reactions reported by at least 2% of people on Zepbound® and more often than placebo. Dry mouth falls below that line, so it sits in a short separate paragraph of section 6.1: in the pooled SURMOUNT-1 and SURMOUNT-2 trials, a dry mouth or dry throat affected 1% of people on Zepbound® against 0.1% on placebo. [1] The Canadian monograph places the same finding in its main table because it uses a 1% threshold, and it breaks the figure down by dose. [3]
| Source and population | Zepbound® | Placebo | Notes |
|---|---|---|---|
| US label §6.1, SURMOUNT-1 and -2, all doses pooled [1] | 1% | 0.1% | Reported as “dry mouth or dry throat” |
| Canadian monograph, Table 2: 5 / 10 / 15 mg [3] | 5 (0.8%) / 11 (1.2%) / 7 (0.7%) patients | 1 (0.1%) | Listed under gastrointestinal disorders |
| Canadian patient information [3] | Listed | — | Among “possible side effects” |
| EU, tirzepatide sold as Mounjaro® [4] | Not listed | — | No Zepbound® EPAR exists |
| US Medication Guide [2] | Not named | — | Asks you to drink fluids to reduce dehydration |
What research has looked at
There are no dedicated trials of dry mouth with tirzepatide. A 2026 review of oral and salivary effects of GLP-1 medicines and tirzepatide gathered case reports, spontaneous reports and laboratory work, and described dry mouth, reduced saliva, taste changes and burning or throat discomfort among reported problems. [5] It proposed three possible routes: a direct effect on signalling in the salivary glands, altered nerve control of saliva, and dehydration from stomach side effects. The authors stressed that the evidence is limited and mostly indirect. [5]
An analysis of ear, nose and throat reports in the FDA’s spontaneous reporting system covered five GLP-1 medicines including tirzepatide. Its abstract reports a dry mouth signal for semaglutide but does not name one for tirzepatide. [6] Reporting systems cannot show cause or frequency, and tirzepatide had been on the market for a shorter time than the others.
Fluid loss: the reason dry mouth matters
Gastrointestinal reactions were the most common Zepbound® side effects, reported by 56% at each dose versus 30% on placebo, and most nausea, vomiting and diarrhea happened while the dose was being raised. [1] The label’s warning on acute kidney injury explains that such losses can lead to dehydration, and asks clinicians to watch kidney function especially when starting and stepping up the dose. [1]
MedlinePlus lists a dry or sticky mouth alongside thirst, passing less urine, darker yellow urine, headache and muscle cramps as signs of mild to moderate dehydration. [10] The Canadian patient information describes dehydration that needs a clinician as dark yellow, strong-smelling urine, extreme thirst and feeling dizzy or light-headed. [3] So a dry mouth in a week with vomiting or diarrhea deserves more attention than one on an ordinary day.
Other things that dry the mouth
The National Institute of Dental and Craniofacial Research notes that hundreds of medicines can reduce saliva, including some for high blood pressure, depression and bladder control. It also names diseases such as diabetes and Sjögren’s disease, cancer treatment and nerve damage. [9] Feeling nervous or stressed can dry the mouth temporarily. [9]
Two causes are worth checking in people who use Zepbound®. High blood sugar in diabetes can cause strong thirst and a dry mouth, [11] which is relevant for those with type 2 diabetes, as in SURMOUNT-2. And sleep apnea, for which Zepbound® is approved in adults with obesity, lists dry mouth among its symptoms, so a dry mouth on waking may point to sleep rather than to the injection. [1][7]
Relief steps from health agencies
MedlinePlus suggests sipping water or a sugar-free drink with meals, chewing sugar-free gum or sucking sugar-free hard sweets to stimulate saliva, limiting caffeinated drinks, which can dry the mouth, and avoiding tobacco and alcohol. [8] It also notes that spicy or salty food can sting a dry mouth. [8]
Saliva protects the teeth, and a persistently dry mouth raises the risk of tooth decay and mouth infections, according to the National Institute of Dental and Craniofacial Research; it advises good oral care and regular dental check-ups. [9] If another medicine is the likely cause, your doctor or dentist may consider alternatives or a saliva substitute; [9] do not change any medicine on your own.
Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Eli Lilly and Company.
When to get help
| Sign | Who to contact | How fast | Source |
|---|---|---|---|
| Swelling of the tongue, lips, face or throat, or trouble breathing or swallowing | Stop Zepbound® and get emergency help (911 or local number) | Emergency | Medication Guide [2] |
| Very dark or amber urine or no urine, confusion, a racing heart or fainting | Emergency care (severe dehydration) | Emergency | MedlinePlus [10] |
| Dry mouth with ongoing vomiting or diarrhea, extreme thirst or feeling light-headed | Your prescriber, the same day | Today | Medication Guide [2]; Canadian patient information [3] |
| Strong thirst and dry mouth with high glucose readings if you have diabetes | Contact your diabetes care team | Today | MedlinePlus [11] |
| A dry mouth that persists for weeks, mouth sores or trouble chewing and swallowing | Your dentist or doctor | At your next appointment | NIDCR [9] |
